Sean Maduck, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 120,038 shares at $68.52 ($4.7M) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($4.7M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,024 | $0 | 0.0% |
| 2 | $0.00 | 40,000 | $0 | 0.0% |
| 3 | $67.53 | 27,865 | $1.9M | 39.6% |
| 4 | $67.53 | 27,865 | $1.9M | 39.6% |
| 5 | $68.52 | 5,428 | $372K | 7.8% |
| 6 | $68.52 | 5,428 |
| $372K |
| 7.8% |
| 7 | $69.70 | 1,714 | $119K | 2.5% |
| 8 | $69.70 | 1,714 | $119K | 2.5% |
| Total | $39.54 avg | 120,038 | $4.7M | 100% |
| Filing → |
| CORT | SELL | 2026-08-18 | $419K | — | Filing → |
| CORT | SELL | 2026-08-12 | $118K | — | Filing → |
| CORT | SELL | 2026-08-05 | $2.3M | — | Filing → |